Biotechnology News CARDENE Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-9 out of 9 found

Current Search: cardene: 9

EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene I.V
BEDMINSTER, N.J.--(BUSINESS WIRE)--Aug.

5, 2008 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received approval from the U.S.

Pharma Live: Aug 7 2008 3:39PM
Matching: cardene

Find similar documents

FDA OKs Medicines Co.'s Cleviprex (Update)
The Medicines Co.

MDCO said Monday that the Food and Drug Administration approved its intravenous drug to reduce blood pressure.

Shares were climbing 86 cents, or 3.8%, at $23.46 in recent trading Monday morning.

Cleviprex is indicated...

TheStreet.com: Aug 4 2008 5:41PM
Matching: cardene

Find similar documents

FDA OKs Medicines Co.'s Cleviprex
The Medicines Co.

MDCO said Monday that the Food and Drug Administration approved its intravenous drug to reduce blood pressure.

Shares were climbing $1.10, or 4.9%, at $23.10 in recent trading Monday morning.

Cleviprex is indicated...

TheStreet.com: Aug 4 2008 3:16PM
Matching: cardene

Find similar documents

FDA OKs Medicines Co.'s Cleviprex
The Medicines Co.

MDCO said Monday that the Food and Drug Administration approved its intravenous drug to reduce blood pressure.

Shares were climbing $1.10, or 4.9%, at $23.10 in recent trading Monday morning.

Cleviprex is indicated...

TheStreet.com: Aug 4 2008 2:44PM
Matching: cardene

Find similar documents

FDA OKs Medicines Co.'s Cleviprex (Update)
The Medicines Co.

MDCO Shares were climbing 86 cents, or 3.8%, at $23.46 in recent trading Monday morning.

Cleviprex is indicated for when oral therapy is unfeasible or undesirable.

It has a speedy onset and offset of action and is...

TheStreet.com: Aug 4 2008 3:54PM
Matching: cardene

Find similar documents

EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V
- EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received approval from the U.S.

Food and Drug Administration for Cardene(R) I.V....

DiGiTAL50: Aug 2 2008 10:05AM
Matching: cardene

Find similar documents

FDA Approves New Cardene Formulation
CEDAR KNolls, NJ, Aug.

1, 2008-EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received FDA approval for Cardene I.V.

...

Pharmalive.com: Aug 2 2008 2:06AM
Matching: cardene

Find similar documents

EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V
, 7:07 AM EST News source: Business Wire EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received approval from the U.S.

Food and...

Genetic Engineering News: Aug 1 2008 12:25PM
Matching: cardene

Find similar documents

FDA Approves New Cardene Formulation
CEDAR KNolls, NJ, Aug.

...

Pharma Live: Aug 1 2008 3:02PM
Matching: cardene

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.